GC
SCLN

Guggenheim Capital’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Guggenheim Capital’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-169,952
Closed -$1.9M – 2914
2017
Q3 		$1.9M Sell
169,952
-76,079
-31% -$851K ﹤0.01% 1708
2017
Q2 		$2.71M Buy
246,031
+80,709
+49% +$888K 0.01% 1411
2017
Q1 		$1.62M Sell
165,322
-19,500
-11% -$191K ﹤0.01% 1802
2016
Q4 		$2M Buy
+184,822
New +$2M 0.01% 1688